Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2014/064564external-prioritypatent/WO2015044836A1/en
Application filed by PfizerfiledCriticalPfizer
Publication of PH12016500509A1publicationCriticalpatent/PH12016500509A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
PH12016500509A2014-09-162016-03-15Compositions comprising heterogeneous populations of recombinant human clotting factor xa proteins
PH12016500509A1
(en)